Suppr超能文献

小细胞肺癌患者阳性淋巴结的对数优势比与生存的相关性:来自监测、流行病学和最终结果(SEER)数据库的结果

Association of log odds of positive lymph nodes with survival in patients with small cell lung cancer: Results from the SEER database.

作者信息

Gao Ting, Chang Yingxuan, Yue Hongmei

机构信息

The First Clinical Medical College of Lanzhou University, Gansu, P.R. China; Department of Respiratory and Critical Care Medicine, Xianyang Central Hospital, Shaanxi, P.R. China.

The First Clinical Medical College of Lanzhou University, Gansu, P.R. China.

出版信息

Clinics (Sao Paulo). 2024 May 1;79:100369. doi: 10.1016/j.clinsp.2024.100369. eCollection 2024.

Abstract

OBJECTIVES

The prognosis of patients with Small Cell Lung Cancer (SCLC) can be predicted by their Lymph Node (LN) status. The authors aimed to assess the correlations between SCLC survival and number of LN Ratio (LNR), positive LN (pLNs), and Logarithmic Odds of positive LN (LODDS).

METHODS

This cohort study retrospectively included 1,762 patients with SCLC from the SEER database 2004‒2015. The X-tile software was used to determine the cutoff values for pLNs, LNR, and LODDS. The correlations between pLNs, LNR, and LODDS with Overall Survival (OS) and Cancer-Specific Survival (CSS) were explored using Cox regression analysis. The study used the C-index to assess the predictive value of LNR, pLNs, and LODDS on survival.

RESULTS

Among these 1,762 patients, 121 (6.87%) were alive, 1,641 (93.13%) died, and 1,532 (86.95%) died of SCLC. In univariable COX analysis, LNR, pLNs, and LODDS all showed a correlation with CSS and OS (p < 0.05). In multivariable COX analysis, only patients with LODDS (> 0.3 vs. ≤ 0.3) were related to both worse OS (HR = 1.28, 95% CI 1.10‒1.50) and CSS (HR = 1.29, 95% CI 1.10‒1.51), but no correction was observed between LNR and pLNs and survival (p > 0.05). The C-indices for predicting OS for LODDS were 0.552 (95% CI 0.541‒0.563), for LNR 0.504 (95% CI 0.501‒0.507), and for pLNs 0.527 (95% CI 0.514‒0.540). Moreover, the association between LODDS and prognosis in SCLC patients was significant only in patients with LN stage N1 and N2, but not in stage N3.

CONCLUSION

LODDS may be better than other LN assessment tools at predicting survival in SCLC patients.

摘要

目的

小细胞肺癌(SCLC)患者的预后可通过其淋巴结(LN)状态来预测。作者旨在评估SCLC生存率与淋巴结比值(LNR)、阳性淋巴结(pLNs)以及阳性淋巴结对数优势比(LODDS)之间的相关性。

方法

这项队列研究回顾性纳入了2004 - 2015年SEER数据库中的1762例SCLC患者。使用X-tile软件确定pLNs、LNR和LODDS的临界值。采用Cox回归分析探讨pLNs、LNR和LODDS与总生存期(OS)和癌症特异性生存期(CSS)之间的相关性。该研究使用C指数评估LNR、pLNs和LODDS对生存的预测价值。

结果

在这1762例患者中,121例(6.87%)存活,1641例(93.13%)死亡,1532例(86.95%)死于SCLC。在单变量COX分析中,LNR、pLNs和LODDS均与CSS和OS相关(p < 0.05)。在多变量COX分析中,仅LODDS(> 0.3 vs. ≤ 0.3)的患者与较差的OS(HR = 1.28,95%CI 1.10 - 1.50)和CSS(HR = 1.29,95%CI 1.10 - 1.51)相关,但未观察到LNR和pLNs与生存之间的相关性(p > 0.05)。预测OS的LODDS的C指数为0.552(95%CI 0.541 - 0.563),LNR为0.504(95%CI 0.501 - 0.507),pLNs为0.527(95%CI 0.514 - 0.540)。此外,LODDS与SCLC患者预后之间的关联仅在LN分期为N1和N2的患者中显著,而在N3期患者中不显著。

结论

在预测SCLC患者的生存方面,LODDS可能优于其他LN评估工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca4/11070598/1b7a174689f4/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验